Eli Lilly to Acquire Centessa Pharmaceuticals

Eli Lilly agreed to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders. The transaction is described as a merger and framed as an expansion into sleep medicine.

Centessa Pharmaceuticals is the target company in the deal, and the buyer is Eli Lilly. The excerpt provides the strategic focus on sleep-wake disorder therapeutics but does not include financial terms.